TMEM106B and frontotemporal dementia: Transmembrane protein 106B (TMEM106B) is 274-residue protein whose gene locus was initially identified by a genome-wide association study to be a risk factor for the occurrence of frontotemporal lobar degeneration (FTLD), which is the second most common form of progressive dementia in people under 65 years [1,2].